Global Healthcare Analytical Testing Services Market Size study & Forecast, by Testing Type and End User and Regional Forecasts 2025-2035

Description

The Global Healthcare Analytical Testing Services Market is valued approximately at USD 6.75 billion in 2024 and is projected to expand with a CAGR of more than 10.80% during the forecast period 2025-2035. Analytical testing services have become indispensable to the healthcare ecosystem as drug developers, medtech manufacturers, and hospitals increasingly rely on specialized third-party expertise to validate safety, efficacy, and compliance of their products. These services encompass a broad spectrum of testing methodologies, ranging from bioanalytical and microbial testing to advanced genomic and stability assessments, ensuring that healthcare products consistently meet stringent regulatory benchmarks. The market's robust expansion is underpinned by rising global healthcare expenditures, the proliferation of complex biologics, and the escalating pace of pharmaceutical R&D. In particular, the growing outsourcing trend within the pharmaceutical and medical device industries is accelerating demand, as companies strive to streamline timelines and achieve regulatory approvals more efficiently.

The surge in demand for biopharmaceuticals and precision medicine has substantially fueled the need for analytical testing services. Biologics, cell-based therapies, and genomic-driven treatments require rigorous, multi-layered validation processes before they can be introduced into clinical practice. This has created a fertile environment for service providers to innovate and broaden their offerings. For instance, stability and batch-release testing have become central to ensuring drug integrity across global supply chains, particularly as biologics require cold-chain logistics and tightly monitored conditions. According to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), global spending on medicines is projected to surpass USD 1.9 trillion by 2027, with a significant share devoted to innovative biologics and precision therapies. Although the increasing adoption of renewable health technologies and decentralized diagnostic solutions presents potential challenges to traditional laboratory services, advancements in testing platforms and deeper integration with clinical pipelines are expected to counterbalance these constraints.

The detailed segments and sub-segments included in the report are:

By Testing Type:

Cell-based
Bioanalytical
Raw Material
Microbial
Stability
Batch-release
Genomic
Method Development & Validation

By End User:

Pharma
MedTech
Hospital

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa
Among end users, the pharmaceutical sector is anticipated to dominate the market throughout the forecast period. Pharma companies continue to outsource a considerable proportion of their testing requirements to third-party laboratories to accelerate drug development pipelines, ensure stringent compliance with FDA and EMA standards, and reduce overhead costs. This segment accounts for the lion's share of demand, owing to the sheer volume of small-molecule and biologic drugs under development globally. Meanwhile, MedTech companies are rapidly adopting analytical testing services to ensure product safety, precision, and adherence to evolving regulatory frameworks, thereby creating incremental opportunities in the segment. Hospitals, though smaller in share, are increasingly leveraging specialized genomic and microbial testing capabilities to improve diagnostics and patient outcomes.
When analyzing the market by testing type, bioanalytical testing commands the largest revenue share, driven by its indispensable role in biologics, biosimilars, and advanced therapeutics validation. These tests are vital for pharmacokinetics, immunogenicity, and biomarker analysis, ensuring both safety and efficacy profiles of novel therapies. While bioanalytical remains dominant in revenue, genomic testing is poised to witness the fastest growth rate over the coming years, propelled by the rapid adoption of personalized medicine, the rise in genetic disorder diagnoses, and decreasing costs of sequencing technologies. Stability and batch-release testing also continue to gain traction due to globalization of drug supply chains, where consistent product integrity is paramount.
Regionally, North America held the dominant share in 2024 and is projected to maintain its lead in 2025, owing to its advanced healthcare infrastructure, strong regulatory frameworks, and substantial R&D investments by pharmaceutical and biotechnology companies. The U.S., in particular, benefits from a highly active drug pipeline and concentration of global CROs offering sophisticated testing services. Europe follows closely, supported by robust regulatory oversight and expanding biologics market, especially in Germany, France, and the UK. Asia Pacific, however, is forecasted to be the fastest-growing region during 2025-2035, fueled by rapid expansion of pharmaceutical manufacturing in China and India, rising healthcare investments, supportive government policies, and the proliferation of local CROs. Meanwhile, Latin America and the Middle East & Africa are steadily emerging as attractive outsourcing destinations due to cost advantages and increasing adoption of global testing standards.

Major market players included in this report are:

Eurofins Scientific
Charles River Laboratories
SGS SA
WuXi AppTec
Intertek Group Plc
PPD (part of Thermo Fisher Scientific)
Labcorp Drug Development
Covance Inc.
ICON Plc
Syneos Health
Pace Analytical Services
Almac Group
Envigo
BioAgilytix Labs
Q2 Solutions

Global Healthcare Analytical Testing Services Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional-level analysis for each market segment.
Detailed analysis of the geographical landscape with country-level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of the competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Healthcare Analytical Testing Services Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. key Findings

Chapter 3. Global Healthcare Analytical Testing Services Market Forces Analysis

3.1. Market Forces Shaping The Global Healthcare Analytical Testing Services Market (2024-2035)
3.2. Drivers
- 3.2.1. Proliferation of complex biologics
- 3.2.2. The escalating pace of pharmaceutical R&D
3.3. Restraints
- 3.3.1. Increasing adoption of renewable health technologies and decentralized diagnostic solutions
3.4. Opportunities
- 3.4.1. Rising global healthcare expenditures

Chapter 4. Global Spacer Fluid Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Healthcare Analytical Testing Services Market Size & Forecasts by Testing Type 2025-2035

5.1. Market Overview
5.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
5.3. Cell Based
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Bioanalytical
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. Raw Material
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035
5.6. Microbial
- 5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.6.2. Market size analysis, by region, 2025-2035
5.7. Stability
- 5.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.7.2. Market size analysis, by region, 2025-2035
5.8. Batch Release
- 5.8.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.8.2. Market size analysis, by region, 2025-2035
5.9. Genomic
- 5.9.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.9.2. Market size analysis, by region, 2025-2035
5.10. Method Development and Validation
- 5.10.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.10.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Healthcare Analytical Testing Services Market Size & Forecasts by End User 2025-2035

6.1. Market Overview
6.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
6.3. Pharma
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Medtech
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
6.5. Hospital
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Healthcare Analytical Testing Services Market Size & Forecasts by Region 2025-2035

7.1. Growth Healthcare Analytical Testing Services Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Healthcare Analytical Testing Services Market
- 7.3.1. U.S. Healthcare Analytical Testing Services Market
  - 7.3.1.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.3.1.2. End User breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Healthcare Analytical Testing Services Market
  - 7.3.2.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.3.2.2. End User breakdown size & forecasts, 2025-2035
7.4. Europe Healthcare Analytical Testing Services Market
- 7.4.1. UK Healthcare Analytical Testing Services Market
  - 7.4.1.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.4.1.2. End User breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Healthcare Analytical Testing Services Market
  - 7.4.2.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.4.2.2. End User breakdown size & forecasts, 2025-2035
- 7.4.3. France Healthcare Analytical Testing Services Market
  - 7.4.3.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.4.3.2. End User breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Healthcare Analytical Testing Services Market
  - 7.4.4.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.4.4.2. End User breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Healthcare Analytical Testing Services Market
  - 7.4.5.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.4.5.2. End User breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Healthcare Analytical Testing Services Market
  - 7.4.6.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.4.6.2. End User breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Healthcare Analytical Testing Services Market
- 7.5.1. China Healthcare Analytical Testing Services Market
  - 7.5.1.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.5.1.2. End User breakdown size & forecasts, 2025-2035
- 7.5.2. India Healthcare Analytical Testing Services Market
  - 7.5.2.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.5.2.2. End User breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Healthcare Analytical Testing Services Market
  - 7.5.3.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.5.3.2. End User breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Healthcare Analytical Testing Services Market
  - 7.5.4.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.5.4.2. End User breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Healthcare Analytical Testing Services Market
  - 7.5.5.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.5.5.2. End User breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Healthcare Analytical Testing Services Market
  - 7.5.6.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.5.6.2. End User breakdown size & forecasts, 2025-2035
7.6. Latin America Healthcare Analytical Testing Services Market
- 7.6.1. Brazil Healthcare Analytical Testing Services Market
  - 7.6.1.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.6.1.2. End User breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Healthcare Analytical Testing Services Market
  - 7.6.2.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.6.2.2. End User breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Healthcare Analytical Testing Services Market
- 7.7.1. UAE Healthcare Analytical Testing Services Market
  - 7.7.1.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.7.1.2. End User breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Healthcare Analytical Testing Services Market
  - 7.7.2.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.7.2.2. End User breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Healthcare Analytical Testing Services Market
  - 7.7.3.1. Testing Type breakdown size & forecasts, 2025-2035
  - 7.7.3.2. End User breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Eurofins Scientific
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Charles River Laboratories
8.4. SGS SA
8.5. WuXi AppTec
8.6. Intertek Group Plc
8.7. PPD (part of Thermo Fisher Scientific)
8.8. Labcorp Drug Development
8.9. Covance Inc.
8.10. ICON Plc
8.11. Syneos Health
8.12. Pace Analytical Services
8.13. Almac Group
8.14. Envigo
8.15. BioAgilytix Labs
8.16. Q2 Solutions